BridgeBio Pharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BridgeBio Pharma, Inc. has filed 827 SEC EDGAR filings since 19 Jun 2018

SEC filing history

Showing 201-225 of 827 matching filings.

Per page
25
Current page
9
SCHEDULE 13D/A File 005-91059

SCHEDULE 13D/A filing

Filing date
14 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 May 2025
Reporting date
12 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38959

144 filing

Filing date
12 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 May 2025
Reporting date
07 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38959

DEFA14A

Filing date
09 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 May 2025
Reporting date
02 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 May 2025
Reporting date
02 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38959

144 filing

Filing date
02 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38959

DEFA14A

Filing date
30 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38959

ARS

Filing date
30 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38959

DEF 14A

Filing date
30 Apr 2025
Reporting date
20 Jun 2025
Next action
Verify source filing
4

4

Filing date
24 Apr 2025
Reporting date
22 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Apr 2025
Reporting date
14 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-38959

PRE 14A

Filing date
16 Apr 2025
Reporting date
20 Jun 2025
Next action
Verify source filing
144 File 001-38959

144 filing

Filing date
14 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Apr 2025
Reporting date
01 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38959

144 filing

Filing date
02 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Mar 2025
Reporting date
25 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Mar 2025
Reporting date
19 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Mar 2025
Reporting date
19 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Mar 2025
Reporting date
19 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91059

SCHEDULE 13D/A filing

Filing date
12 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .